TP53 and acute myeloid leukemia: These 20 cases corresponded to the following genomic categories: TP53 disruption/aneuploidy (n = 6), chromatin/spliceosome mutations (n = 11), and homozygous JAK2 mutation (n = 3), with no case of AML progression recorded in the remaining genomic categories.